RU96122371A - METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE ANALYSIS - Google Patents

METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE ANALYSIS

Info

Publication number
RU96122371A
RU96122371A RU96122371/14A RU96122371A RU96122371A RU 96122371 A RU96122371 A RU 96122371A RU 96122371/14 A RU96122371/14 A RU 96122371/14A RU 96122371 A RU96122371 A RU 96122371A RU 96122371 A RU96122371 A RU 96122371A
Authority
RU
Russia
Prior art keywords
day
treating endogenous
postoperative
uveitis
postoperative analysis
Prior art date
Application number
RU96122371/14A
Other languages
Russian (ru)
Other versions
RU2107480C1 (en
Inventor
О.С. Слепова
В.Н. Кушнир
В.В. Лебедев
О.Г. Степанов
Т.М. Шелепова
Original Assignee
Московский научно-исследовательский институт глазных болезней им.Гельмгольца
Государственный медицинский университет Республики Молдова
Filing date
Publication date
Application filed by Московский научно-исследовательский институт глазных болезней им.Гельмгольца, Государственный медицинский университет Республики Молдова filed Critical Московский научно-исследовательский институт глазных болезней им.Гельмгольца
Priority to RU96122371A priority Critical patent/RU2107480C1/en
Priority claimed from RU96122371A external-priority patent/RU2107480C1/en
Application granted granted Critical
Publication of RU2107480C1 publication Critical patent/RU2107480C1/en
Publication of RU96122371A publication Critical patent/RU96122371A/en

Links

Claims (1)

Способ лечения эндогенных и послеоперационных увеитов путем иммунокорригирующей терапии, отличающийся тем, что в качестве иммунокорригирующего средства используют "Имунофан", который вводят в виде субконъюнктивальных инъекций при передних увеитах или парабульбарных инъекций при задних увеитах в дозе 0,5 мл 0,005% раствора один раз в сутки, ежедневно в первые пять дней и затем через день при общем курсе от 5 до 15 инъекций.A method of treating endogenous and postoperative uveitis by immunocorrective therapy, characterized in that Imunofan is used as immunocorrective agent, which is administered as subconjunctival injection for anterior uveitis or parabulbar injection for posterior uveitis at a dose of 0.5 ml of a 0.005% solution once every once day, every day for the first five days and then every other day with a general course of 5 to 15 injections.
RU96122371A 1996-11-22 1996-11-22 Method for treating endogenous and postoperative uveitis RU2107480C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96122371A RU2107480C1 (en) 1996-11-22 1996-11-22 Method for treating endogenous and postoperative uveitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96122371A RU2107480C1 (en) 1996-11-22 1996-11-22 Method for treating endogenous and postoperative uveitis

Publications (2)

Publication Number Publication Date
RU2107480C1 RU2107480C1 (en) 1998-03-27
RU96122371A true RU96122371A (en) 1998-09-10

Family

ID=20187501

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96122371A RU2107480C1 (en) 1996-11-22 1996-11-22 Method for treating endogenous and postoperative uveitis

Country Status (1)

Country Link
RU (1) RU2107480C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD371Z5 (en) * 2010-11-22 2012-04-30 Общественное Медико-Санитарное Учреждение Институт Фтизиопневмологии Кирила Драганюка Method for treating the ocular tuberculosis

Similar Documents

Publication Publication Date Title
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
DE69230112D1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
TR199801180T2 (en) New compounds with analgesic effect.
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
NO920051D0 (en) PHARMACEUTICAL COMPOSITION FOR SLIMMING
EP0947222A3 (en) Method of activating photosensitive agents
KR910019618A (en) Pharmaceutical composition for treating erectile dysfunction
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
DE69914084D1 (en) PHENYLACETYLGLUTAMINE, PHENYLACETYLISOGLUTAMINE, AND / OR PHENYLACETATE FOR TREATING NEOPLASTIC DISEASES
ES2106531T3 (en) DIBENZOXAZEPINE COMPOUNDS SUBSTITUTED IN 2, 3, 4, 5, 6, 7, 8, 9 AND / OR 10, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
TR199801184T2 (en) New compounds with analgesic action.
KR890012942A (en) 5-substituted ornithine derivatives
RU96122371A (en) METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE ANALYSIS
EA200000141A1 (en) METHOD OF TREATMENT OF DIABETAS BY THIAZOLIDINDIONE AND SULFONYL URIDE
HUP9903679A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
KR880004810A (en) Peptic Ulcer Treatment
KR920003977A (en) Kidney disease treatment
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR920702676A (en) New stereoisomers
KR890012651A (en) Diuretic or antihypertensive compositions
EP0318889A3 (en) Method for treatment of dyslipidemia in humans
KR910004603A (en) New compounds
KR890007737A (en) Anti-caking agents
RU94003799A (en) METHOD FOR TREATING ANIMAL PSOROPTOSES